[CQM-6754] Inquiry Regarding CMS104v11 Discharged on Antithrombotic Therapy Created: 02/12/24 Updated: 02/15/24 Resolved: 02/15/24 |
|
| Status: | Closed |
| Project: | eCQM Issue Tracker |
| Component/s: | None |
| Type: | EC eCQMs - Eligible Clinicians | Priority: | Moderate |
| Reporter: | Megan Carlucci | Assignee: | Joelencia Leflore |
| Resolution: | Answered | Votes: | 0 |
| Labels: | None | ||
| Contact Name: | Megan Carlucci |
| Contact Email: | carlucci@ncqa.org |
| Contact Phone: | 2020551727 |
| Institution/Name: | National Committee for Quality Assurance (NCQA) |
| Solution: | Thank you for your question regarding CMS104v11, STK-2: Discharged on Antithrombotic Therapy. CMS104v11 is an inpatient measure, and an inpatient encounter must end during the measurement period in order to be included in any of the stroke measures. Many places in STK-2 extend the inpatient encounter to the entire hospitalization (including observation and ED) using Global.”HospitalizationWithObservation”. Global.”HospitalizationWithObservation” which groups ED, observation and inpatient encounters into a hospitalization. If the patient is not admitted to inpatient status they are not included in the measure. |
| Solution Posted On: | |
| 2023 Reporting Period Hosp Inpt eCQMs: |
CMS0104v11
|
| Impact: | Are observation patients included or excluded in the initial population for this measure? |
| Comments |
| Comment by Joelencia Leflore [ 02/13/24 ] |
|
Thank you for submitting your question. We will review your ticket and provide a response as soon as possible. |